Ross Mason

1.7k total citations
59 papers, 997 citations indexed

About

Ross Mason is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ross Mason has authored 59 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 18 papers in Surgery. Recurrent topics in Ross Mason's work include Renal cell carcinoma treatment (25 papers), Renal and related cancers (17 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Ross Mason is often cited by papers focused on Renal cell carcinoma treatment (25 papers), Renal and related cancers (17 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Ross Mason collaborates with scholars based in Canada, United States and United Kingdom. Ross Mason's co-authors include Stephen A. Boorjian, Bimal Bhindi, Ricardo Rendon, R. Houston Thompson, Bradley C. Leibovich, Christine M. Lohse, David Bell, Joseph Lawen, John C. Cheville and Mohamed Abdolell and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and European Urology.

In The Last Decade

Ross Mason

53 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Mason Canada 17 748 436 303 220 122 59 997
Nicole Benfante United States 18 749 1.0× 213 0.5× 397 1.3× 153 0.7× 69 0.6× 99 1.1k
Nawar Hanna United States 15 570 0.8× 271 0.6× 529 1.7× 180 0.8× 40 0.3× 38 951
Vincent Hupertan France 19 723 1.0× 362 0.8× 532 1.8× 104 0.5× 51 0.4× 47 1.2k
Rajinikanth Ayyathurai United States 16 530 0.7× 165 0.4× 399 1.3× 102 0.5× 114 0.9× 43 921
Patrick A. Kenney United States 17 354 0.5× 326 0.7× 332 1.1× 68 0.3× 29 0.2× 51 852
B. Hoschke Germany 16 349 0.5× 153 0.4× 478 1.6× 167 0.8× 27 0.2× 69 943
Rayan Matloob Italy 16 423 0.6× 339 0.8× 229 0.8× 34 0.2× 31 0.3× 45 773
Madhur Nayan Canada 16 227 0.3× 158 0.4× 282 0.9× 115 0.5× 31 0.3× 51 593
David J. Hernandez United States 16 694 0.9× 79 0.2× 196 0.6× 138 0.6× 32 0.3× 27 869
Philipp Dahm United States 5 240 0.3× 100 0.2× 202 0.7× 84 0.4× 31 0.3× 9 481

Countries citing papers authored by Ross Mason

Since Specialization
Citations

This map shows the geographic impact of Ross Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Mason more than expected).

Fields of papers citing papers by Ross Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Mason. The network helps show where Ross Mason may publish in the future.

Co-authorship network of co-authors of Ross Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Mason. A scholar is included among the top collaborators of Ross Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Mason. Ross Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rendon, Ricardo, et al.. (2024). An in-depth analysis on the effects of body composition in patients receiving neoadjuvant chemotherapy for urothelial cell carcinoma. Canadian Urological Association Journal. 18(6). 180–184. 3 indexed citations
2.
Mason, Ross, et al.. (2024). Is the excretory phase necessary to identify upper tract urothelial neoplasms at CT urography? A 10-year population-based study. Abdominal Radiology. 49(7). 2296–2304. 3 indexed citations
4.
Ilie, G., Ross Mason, Ricardo Rendon, et al.. (2024). Six-Month Prostate Cancer Empowerment Program (PC-PEP) Improves Urinary Function: A Randomized Trial. Cancers. 16(5). 958–958. 5 indexed citations
5.
Mason, Ross, et al.. (2024). Robotic-assisted laparoscopic partial nephrectomy vs. laparoscopic and open partial nephrectomy. Canadian Urological Association Journal. 18(8). 245–250. 4 indexed citations
6.
Mason, Ross, et al.. (2023). Therapeutic Approaches to Penile Cancer: Standards of Care and Recent Developments. Research and Reports in Urology. Volume 15. 165–174. 6 indexed citations
7.
Rendon, Ricardo, et al.. (2023). A comparison of the sarcopenic effect of androgen receptor-axis-targeted agents vs. androgen deprivation alone in patients with metastatic prostate cancer. Canadian Urological Association Journal. 17(8). 274–279. 2 indexed citations
9.
10.
Rendon, Ricardo, et al.. (2022). Utility of Postoperative Serial Renal Function Monitoring in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma. Annals of Surgical Oncology. 29(8). 5333–5337. 1 indexed citations
11.
Ory, Jesse, et al.. (2021). Urological outcomes in nonagenarians with prostate cancer. Canadian Urological Association Journal. 15(8). E393–E396.
12.
Lavallée, Luke T., Kristen McAlpine, Anil Kapoor, et al.. (2019). Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of renal mass biopsy in the management of kidney cancer. Canadian Urological Association Journal. 13(12). 377–383. 8 indexed citations
13.
Bhindi, Bimal, Christine M. Lohse, Phillip J. Schulte, et al.. (2018). Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. European Urology. 75(5). 766–772. 68 indexed citations
14.
Mason, Ross, Stephen A. Boorjian, Bimal Bhindi, et al.. (2018). Examining the association between adiposity and biochemical recurrence after radical prostatectomy. Canadian Urological Association Journal. 12(7). E331–7. 2 indexed citations
15.
Rendon, Ricardo, Ross Mason, Karim Marzouk, et al.. (2017). Canadian Urological Association recommendations on prostate cancer screening and early diagnosis. Canadian Urological Association Journal. 11(10). 298–309. 49 indexed citations
16.
Bhindi, Bimal, Ross Mason, Stephen A. Boorjian, et al.. (2017). Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis. European Urology. 73(2). 254–259. 43 indexed citations
17.
Mason, Ross, et al.. (2016). Intrinsic ureteral endometriosis as a cause of unilateral obstructive uropathy. Canadian Urological Association Journal. 10(3-4). 119–119.
18.
Mason, Ross, et al.. (2015). Acquired hemophilia A: A rare cause of gross hematuria. Canadian Urological Association Journal. 9(11-12). 905–905. 2 indexed citations
19.
Mason, Ross, Wassim Kassouf, David Bell, et al.. (2012). The Contemporary Role of Lymph Node Dissection During Nephroureterectomy in the Management of Upper Urinary Tract Urothelial Carcinoma: The Canadian Experience. Urology. 79(4). 840–845. 39 indexed citations
20.
Mason, Ross, Mohamed Abdolell, & Ricardo Rendon. (2010). Tumour location as a predictor of benign disease in the management of renal masses. Canadian Urological Association Journal. 4(6). 414–417. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026